TipRanks
Go Ultimate55% OFF

Rising Biosciences (RBII) Financial Statements

Rising Biosciences Financial Overview

Rising Biosciences's market cap is currently $1.06K. The company's EPS TTM is ―; its P/E ratio is 0.21; Rising Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 20Dec 19
Income Statement
Total Revenue$ 782.28K$ 163.73K
Gross Profit$ 448.38K$ -68.94K
Operating Income$ 284.17K$ -179.26K
EBITDA$ 152.69K$ -145.74K
Net Income$ 49.76K$ -253.23K
Balance Sheet
Cash & Short-Term Investments$ 48.00K$ 763.00
Total Assets$ 640.42K$ 400.07K
Total Debt$ 1.06M$ 946.27K
Net Debt$ 1.01M$ 945.50K
Total Liabilities$ 1.73M$ 1.56M
Stockholders' Equity$ -1.09M$ -1.16M
Cash Flow
Free Cash Flow$ -70.34K$ -140.74K
Operating Cash Flow$ -70.34K$ -59.43K
Investing Cash Flow$ -6.06K$ -116.41K
Financing Cash Flow$ 123.63K$ 176.45K

Currency in USD

Rising Biosciences Earnings and Revenue History

-500K0500K1M-200 %-100 %0 %100 %EarningsProfit Margin20192020RevenueEarningsProfit Margin

Rising Biosciences Debt to Assets

0800K1.6M2.4M250 %300 %350 %400 %LiabilitiesDebt to Assets20192020AssetsLiabilitiesDebt to Assets

Rising Biosciences Cash Flow

-200K-100K0100K200K20192020OperatingInvestingFinancing

Rising Biosciences Forecast EPS vs Actual EPS